These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7554453)
1. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity. Sizemore RC; Kern CH; Gottlieb MS; Gottlieb AA Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):308-13. PubMed ID: 7554453 [TBL] [Abstract][Full Text] [Related]
2. Clinical and immunologic observations in patients with AIDS-related complex treated with IMREG-1. Gottlieb AA Int J Immunopharmacol; 1991; 13 Suppl 1():29-32. PubMed ID: 1823905 [TBL] [Abstract][Full Text] [Related]
3. Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo. Fiala M; Cone LA; Sayre JW Int J Immunopharmacol; 1991; 13(7):999-1004. PubMed ID: 1761364 [TBL] [Abstract][Full Text] [Related]
4. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Gottlieb MS; Zackin RA; Fiala M; Henry DH; Marcel AJ; Combs KL; Vieira J; Liebman HA; Cone LA; Hillman KS Ann Intern Med; 1991 Jul; 115(2):84-91. PubMed ID: 1676251 [TBL] [Abstract][Full Text] [Related]
5. Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. Gottlieb AA; Sizemore RC; Gottlieb MS; Kern CH Biotherapy; 1996; 9(1-3):27-31. PubMed ID: 8993754 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants. Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330 [TBL] [Abstract][Full Text] [Related]
7. Induction and monitoring of active delayed type hypersensitivity (DTH) in rats. Beeton C; Chandy KG J Vis Exp; 2007; (6):237. PubMed ID: 18997885 [TBL] [Abstract][Full Text] [Related]
8. Use of tetanus toxoid for testing cell-mediated immunity. Whittingham S; Feery B; Mackay IR Aust N Z J Med; 1982 Oct; 12(5):511-4. PubMed ID: 6758748 [TBL] [Abstract][Full Text] [Related]
10. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397 [TBL] [Abstract][Full Text] [Related]
11. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity. Ptak W; Bereta M; Ptak M; Askenase PW J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404 [TBL] [Abstract][Full Text] [Related]
12. Delayed hypersensitivity skin testing in the Thai adult population. Thongngarm T; Valyasevi AM; Pattanapanyasat K; Udompunturak S J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S195-200. PubMed ID: 17718262 [TBL] [Abstract][Full Text] [Related]
14. Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalin. Sizemore RC; Piva M; Moore L; Gordonov N; Heilman E; Godfrey HP Neuroimmunomodulation; 2004; 11(3):141-8. PubMed ID: 15067205 [TBL] [Abstract][Full Text] [Related]
15. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. van Loveren H; Meade R; Askenase PW J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201 [TBL] [Abstract][Full Text] [Related]
16. Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2. Woodfolk JA; Sung SS; Benjamin DC; Lee JK; Platts-Mills TA J Immunol; 2000 Oct; 165(8):4379-87. PubMed ID: 11035075 [TBL] [Abstract][Full Text] [Related]
17. Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity. Baldridge JR; Ward JR Vaccine; 1997 Mar; 15(4):395-401. PubMed ID: 9141210 [TBL] [Abstract][Full Text] [Related]
18. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity. Gordon EH; Krouse HA; Kinney JL; Stiehm ER; Klaustermeyer WB J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):487-94. PubMed ID: 6355249 [TBL] [Abstract][Full Text] [Related]
19. Tapering immunosuppressive therapy significantly improves in vivo cutaneous delayed type hypersensitivity responses. van Besouw NM; van der Mast BJ; van de Wetering J; Rischen-Vos J; Weimar W Transpl Immunol; 2008 Jul; 19(3-4):229-34. PubMed ID: 18573662 [TBL] [Abstract][Full Text] [Related]
20. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. Kitching AR; Tipping PG; Kurimoto M; Holdsworth SR J Immunol; 2000 Oct; 165(8):4649-57. PubMed ID: 11035108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]